Sarah Jordan - Partner


PDF Print Friendly Page
Sarah Jordan

Download V-Card

Phone: +44 20 7469 2260
Fax: +44 20 7469 2001
Overview News Publications

Professional Profile

Sarah Jordan is a partner in the London office of Kirkland & Ellis International LLP. Her practice focuses on all aspects of European and UK competition law, advising on cartels, mergers, antitrust and State aid issues for European and U.S. clients. Her experience includes work with sectors as diverse as pharmaceuticals, air transport, directory and internet services, basic manufacturing and construction materials, chemicals, brewing, digital storage products, financial services, and paper. Sarah has managed many transactions requiring approval for private equity and other clients before the European Commission, UK Competition & Markets Authority, and has coordinated multijurisdictional notifications in North and South America, Asia, Australia and New Zealand. She has also been engaged in a number of conduct matters, including transatlantic cartel investigations, advising on dawn raid procedures and conducting antitrust audits, and acting on cases before the EC and the European Courts. For her work in Competition Law, Sarah was recognized in 2017 as a “Future Leader” by Who’s Who Legal and in 2014 as a “Rising Star” by Law360.

Prior to joining Kirkland, Sarah worked as a senior associate and as counsel for Howrey, LLP in their London, Brussels and Washington, D.C. offices.

Representative Matters

  • Bain Capital on its acquisition of DSM Sinochem Pharmaceuticals, a global leader in sustainable antibiotics, next-generation statins and anti-fungals.

  • Creat Group Corporation on its acquisition of Biotest AG; securing unconditional UK clearance.

  • Crestview Partners in connection with the acquisition by its subsidiary, Accuride Corporation, of mefro wheels; conditional EU Phase I clearance.

  • Material Handling Systems, Inc., a portfolio company of Thomas H. Lee Partners, on its acquisition of VanRiet Material Handling Systems from Avedon Capital Partners and management.

  • Bain Capital and Cinven on their EUR 5.3 billion joint public takeover offer for the German pharmaceutical company Stada Arzneimittel AG; to date the largest private equity transaction ever realized in the German market.

  • CapVest Partners on its acquisition of Karro Food Group, a leading UK-based pork processing firm, from Endless LLP.

  • Bain Capital Private Equity on its acquisition of leading Italian tyre wholesaler Fintyre. Bain acquired the stake through its Europe IV Fund from London private equity firm BlueGem Capital Partners.

  • Bain Capital Private Equity on the acquisition of MSX International (MSXI).

  • Vista Equity Partners in its $1.6 billion take-private acquisition of Infoblox Inc.

  • Bain Capital Private Equity and Vista Equity Partners on the $2.7 billion acquisition of Vertafore.

  • Vista Equity Partners on the $1.65 billion acquisition of Cvent, Inc.

  • Montagu Private Equity on its sale of CliniSys to Roper Technologies.

  • GTCR on its pending £462 million sale of Premium Credit Limited to Cinven Partners LLP.

  • Ontario Teachers’ Pension Plan on the £365 million acquisition of Bridon Limited.

  • Bain Capital and Advent International on the DKK17 billion acquisition of Nordic card-payment company Nets Holding AS.

  • Ontario Teachers' Pension Plan on the acquisition of Burton's Biscuits Company.

  • Bain Capital on the successful merger control approval of the joint acquisition with Altor of EWOS before the EC and Norwegian authority.

  • Vista Equity Partners on the acquisition of Misys.

  • Lafarge. Successfully representing Lafarge before the European and UK competition authorities on the creation of a joint venture comprising Lafarge and Anglo American (Tarmac)’s UK construction materials businesses.

  • United Airlines. Successfully representing United on the European Commission’s investigation of its merger with Continental.

  • Schering-Plough before the European Commission on its US$41 billion merger with Merck.

  • The Greek government. Advising on the State aid aspects of the restructuring and privatisation of Olympic Airlines and Olympic Airways Services.

  • Anheuser-Busch on the UK merger control review of its acquisition by InBev. The transaction was unconditionally cleared in phase one proceedings.

  • Schering-Plough/Organon BioSciences. Acting on a complex phase one pharmaceutical merger before the European Commission. The case was successfully approved with commitments in phase one proceedings.

  • Tomkins Plc v. European Commission. Representing a shareholder corporation before the European Commission, and in connection with annulment proceedings before the European General Court and Court of Justice.

  • European Commission Acrylics Cartel Investigation. Acting for a large international chemicals company during the European Commission's acrylics investigation.

  • Bio-Rad Laboratories Inc./Carl Zeiss Jena GmbH, Competition Commission (Phase II) Inquiry. Advising Bio-Rad Laboratories on the UK Competition Commission's investigation of Zeiss's acquisition of Bio-Rad's microscopy business.

Memberships & Affiliations

Committee Member and Past-Chair, The Competition Section, Law Society of England and Wales

Member, American Bar Association, Antitrust Section


“EU Antitrust vs. U.S. Companies.” Law360 (February 4, 2016). Co-authored with Paula Riedel and James Mutchnik.

European Union chapter of "Public Competition Enforcement Review." Law Business Research, London (2011). Co-authored with Shaun Goodman.

"State Aid after the Financial Crisis." The European Antitrust Review 2011 (2011). Co-authored with Paris Anestis.

"Expect the Unexpected: How to Manage A Dawn Raid." Antitrust Compliance: Perspectives and Resources for Corporate Counselors (American Bar Association) (2011).

"The Handling of State Aid during the Financial Crisis: an Efficient Response or Trouble for the Future?" The European Antitrust Review 2010 (2010). Co-authored with Paris Anestis.

"Developments in the Law: The Presumption of Shareholder Liability and the Implications for Shareholders in Private Damages Actions." Global Competition Litigation Review, No. Issue 4 (December 2009). Co-authored with John Briggs.

"Bring on the Private Suits." Legal Times XXX, No. 12 (March 19, 2007). Co-authored with Alan M. Wiseman, Julian M. Joshua.

"Shareholder Liability for a Subsidiary's Infringements of Article 81 EC Treaty." Business Law International (January 2007). Co-authored with John Briggs.

"Combinations, Concerted Practices and Cartels: Adopting the Concept of Conspiracy in European Community Competition Law." Northwestern Journal of International Law & Business (Spring 2004). Co-authored with Julian M. Joshua.


Speaker, Antitrust: Implications for M&A and JVs, GCR Live 6th Annual Antitrust Law Leaders Forum, Miami (February 2017).

Speaker, Compliance Workshop, IBC Legal, Advanced EU Competition Law Conference, Brussels (November 2016).

Speaker, IP and antitrust interface issues, Pharmaceutical IP, Licensing Asia Conference, Singapore (November 2009).

Speaker, parent company liability in European cartel cases, England & Wales Law Society, Competition Section (May 2009).

Prior Experience

Howrey, LLP - London
Senior Associate/Counsel, 2007-2011

Howrey, LLP - Brussels
Associate, 2002-2007

DG Competition, European Commission - Brussels
Stagiaire, Financial Services Unit, 1999-2000


© 2018 Kirkland & Ellis LLP